K10;?7@ATL*^@>MGR(?/;@_3F3YC3T
SYSTEM PROCESSING...
K10;?7@ATL*^@>MGR(?/;@_3F3YC3T
SYSTEM PROCESSING...
Posted: 2025-04-20 17:18:53 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-04-20 17:19:01 UTC
Verified By
Rollup News
This study investigates the role of bone marrow endothelial cells (BMECs) and the AKT/mTOR signaling pathway in regulating hematopoietic stem cell (HSC) function. The findings indicate that reduced mTOR signaling in BMECs impairs HSC function, while aged ECs induce aging phenotypes in young HSCs. Activation of inflammatory pathways in BMECs contributes to myeloid-biased differentiation of HSCs, which can be rescued by blocking these pathways.
mTOR signaling in BMECs is critical for HSC function
Aged ECs induce aging phenotypes in young HSCs
Inflammatory pathways in BMECs contribute to myeloid-biased differentiation of HSCs
Blocking inflammatory pathways in BMECs can restore HSC function
Identifying the specific mechanisms by which aged ECs induce aging phenotypes in HSCs
Identifying the key inflammatory pathways in BMECs that drive myeloid-biased differentiation
Developing targeted therapies to modulate mTOR signaling and inflammatory pathways in BMECs to improve HSC function